Your browser doesn't support javascript.
loading
Epithelial Barrier Dysfunction in Chronic Respiratory Diseases.
Carlier, François M; de Fays, Charlotte; Pilette, Charles.
Afiliação
  • Carlier FM; Pole of Pneumology, ENT, and Dermatology, Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium.
  • de Fays C; Department of Pneumology and Lung Transplant, Centre Hospitalier Universitaire UCL Namur, Yvoir, Belgium.
  • Pilette C; Pole of Pneumology, ENT, and Dermatology, Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium.
Front Physiol ; 12: 691227, 2021.
Article em En | MEDLINE | ID: mdl-34248677
ABSTRACT
Mucosal surfaces are lined by epithelial cells, which provide a complex and adaptive module that ensures first-line defense against external toxics, irritants, antigens, and pathogens. The underlying mechanisms of host protection encompass multiple physical, chemical, and immune pathways. In the lung, inhaled agents continually challenge the airway epithelial barrier, which is altered in chronic diseases such as chronic obstructive pulmonary disease, asthma, cystic fibrosis, or pulmonary fibrosis. In this review, we describe the epithelial barrier abnormalities that are observed in such disorders and summarize current knowledge on the mechanisms driving impaired barrier function, which could represent targets of future therapeutic approaches.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Physiol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Physiol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Bélgica